This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Reserpine Treatment of Comorbid Tourette’s Disorder and Tardive Dystonia

Veronica Maria Rojas and Robert K. Davies

Published: October 31, 1999

Article Abstract

Letter to the Editor

Sir: Despite increases in the understanding of the course, psychopathology, and pathophysiology of Tourette’s disorder, the use of neuroleptic medication is still a mainstay of the treatment, leaving the afflicted person vulnerable to the development of tardive dyskinesia or dystonia. Moreover, the treatment of severe forms of tardive dyskinesia or dystonia has been difficult, especially in young people.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: